Pearls and pitfalls in clinical neuroradiology

Seminars in Neurology

Volumn 18, Issue 2, 1998, Pages 221-236

  Moots, Paul L ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Magnetic resonance imaging; Neuroradiology

Indexed keywords

ADULT; AGED; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN RADIOGRAPHY; BRAIN SCINTISCANNING; BRAIN TUMOR; CHOLESTEATOMA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; JUGULAR VEIN; MALE; NEURILEMOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SPINE METASTASIS; TEMPORAL LOBE EPILEPSY; THROMBOSIS;

EID: 13144265781     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040875     Document Type: Review

References (52)

1. Posner JB: Neurological complications of cancer. Philadelphia: F.A. Davis, 1995
2. Wiley RG. ed. Neurological complications of cancer. New York Marcel Dekker, 1995
3. Levin VA, ed. Cancer in the nervous system. New York: Churchill Livingstone, 1996
4. Schold SC, Burger PC, Mendelsohn DB, Glatstein EJ, Mickey BE, Minna JD. Primary tumors of the brain and spinal cord. Boston: Butterworth-Heinemann, 1997
5. Black PM, Loeffler JS, eds. Cancer of the nervous system. Cambridge, Mass: Blackwell Science, 1997
6. Bigner DD, Mclendon RE, Bruner JM, eds. Russell and Rubinstein's pathology of tumors of the nervous system. 1998
7. Burger PC, Scheithauer BW. Tumors of the central nervous system. Bethesda: Armed Forces Institute of Pathology (Fascicle 10), 1994
8. Moots P, Jennings M, Metastases of primary CNS tumors In: Maciunas RJ, ed Advanced techniques in central nervous system metastases. American Association of Neurological Surgeons, 1998:17-34
9. Jennings MT, Slatkin N, D'Angelo M, et al. Neoplastic meningitis as the presentation of occult primitive neuroectodermal tumors. J Child Neurol 1993;8:306-312
10. Jennings MT, Frenchmen M, Shehab T, et al Gliomatosis cerebri presenting as intractable epilepsy during early childhood development J Child Neurol 1995;10:37-45
11. Peterson K, Rosenblum MK, Powers JM, Alvord E, Walker RW, Posner JB. Effect of brain irradiation on demyelinating lesions. Neurology 1993;43:2105-2112
12. Khan OA, Bauserman SC, Rothman MI, Aldrich EF, Panitch HS. Concurrence of multiple sclerosis and brain tumor. clinical considerations. Neurology 1997;48:1330-1333
13. Paydarfar D, de la Monte SM Case records of the Massachusetts General Hospital, (case 12-1997) A 50-year-old woman with multiple sclerosis and an enlarging frontal lobe mass N Engl J Med 1997;336-1163-1171
14. Johnson M, Maciunas R, Dutt P, Clinton ME, Collins R. Granulomatous angiitis masquerading as a mass lesion. Magnetic resonance imaging and stereotactic biopsy findings in a patient with occult Hodgkin's Disease. Surg Neurol 1989;31:49-53
15. DeAngelis LM, Yahalom J, Thaler HT, Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992; 10:635-643
16. Albright AL, Packer RJ, Zimmerman R, Rorke RJ, Boyett J, Hammond GD. Magnetic resonance scans should replace biopsies for diagnosis of diffuse brainstem gliomas: a report from the Children's Cancer Group. Neurosurgery 1993;33:1026-1030
17. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500
18. Abbruzzese JL, Abbruzzese MC, Hess KR, Raber MN, Lenzi R, Frost P. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 1994; 12:1272-1280
19. Johnson MD, Kim PJ, Montine TJ, Maciunas RJ. Stereotactic biopsies: pathological considerations. In: Alexander E, Maciunas RJ, eds. Advances in neurosurgical navigation. New York. Thieme Medical Publishers, (in press)
20. Kelly PJ, Daumas-Duport C, Scheithauer BW, Kall BA, Kipsert DB. Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms Mayo Clin Proc 1987;62:450-459
21. Shapiro WR, Therapy of adult malignant brain tumors: what have the clinical trials taught us? Semin Oncol 1986;13:38-45
22. Grossman SA, Black P, DeAngelis L, et al. NCCN adult brain tumor guidelines. Oncology 1997;11:237-277
23. Shapiro WR, Green SB, Burger PC, et al. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in the postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 1989;71:1-9
24. Curran WJ, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group trials. J Nat Cancer Inst 1993;85:704-710
25. Wood JR, Green SB, Shapiro WR, et al. The prognostic importance of tumor size in malignant gliomas: a computer tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 1988;6:338-343
26. Maciunas RJ, Berger MS, Copeland B, Mayberg MR, Selker R, Allen GS. A technique for interactive image-guided neurosurgical intervention in primary brain tumors. Neurosurg Clin North Am 1996;7:245-266
27. Walker MD, Alexander E, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 1978;49:333-343
28. Delattre J-Y, Uchuya M. Radiotherapy and chemotherapy for gliomas. Curr Opin Oncol 1996;8:196-203
29. Shrieve DC, Loeffler JS. Advances in radiation therapy for brain tumors. Neurol Clin 1995;13:773-793
30. Leibel SA, Scott CB, Loeffler JS. Contemporary approaches to the treatment of malignant gliomas with radiation therapy. Semin Oncol 1994;21:198-219
31. Loeffler JS, Alexander E, Shea WM, et al. Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol 1992;10:1379-1385
32. Chamberlain MC, Barba D, Kormanik P, Shea WM. Stereotactic radiosurgery for recurrent gliomas. Cancer 1994;74:1342-1347
33. Fine HA, Dear KBG, Loeffler JS, Black PMcL, Canellos GP. Metaanalysis of radiation therapy with and without chemotherapy for malignant gliomas in adults. Cancer 1993;71:2585-2597
34. Cairncross JG, Macdonald DR, Ramsay DA. Aggressive oligodendroglioma: a chemosensitive tumor. Neurosurgery 1992;31:78-82
35. Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D, Rattner B. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. J Neurosurg 1992;76:741-745
36. Kyritsis AP, Yung WKA, Bruner J, Gleason MJ, Levin VA. The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 1993;32:365-371
37. Levin VA, Silver P, Hannigan J, et al. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazinc, and vincrisitine (PCV) over BCNU for anaplastic gliomas. NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 1990;18:321-324
38. Grossman SA, Wharam M, Sheidler V, et al. Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma. J Clin Oncol 1997;15 2596-2603
39. Laske DW, Youle RJ, Oldfield EH. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nature Med 1997;3:1362-1368
40. Ram Z, Culver KW, Oshiro EM, et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nature Med 1997;3:1354-1361
41. Macdonald DR, Cascino TL, Schold SC, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-1280
42. Shaw EG, Scheithauer BW, O'Fallon JR, Tazelaar HD, Davis DH. Oligodendrogliomas: the Mayo Clinic experience. J Neurosurg 1992;76:428-434
43. Jennings MT. Neurological complications of radiotherapy. In: Wiley RG, ed. Neurological complications of cancer. New York: Marcel Dekker, 1995:219-240
44. Taphoorn MJB, Schiphorst AK, Snoek FJ, et al. Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy Ann Neurol 1994;36:48-54
45. DeAngelis LM, Delattre J-Y, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989; 39:789-796
46. Moots PL, Maciunas R, Eisert D, Parker R, Abou-Khalil B. The course of seizure disorders in adults with malignant gliomas. Arch Neurol 1995;52:717-724
47. Ruff RL, Posner JB. The incidence of systemic venous thrombosis and the risk of anticoagulation in patients with malignant gliomas. Trans Am Neurol Assoc 1981;16:1-3
48. Olin JW, Young JR, Graor RA, Ruschhaupt WF, Beven EG, Bay JW. Treatment of deep vein thrombosis and pulmonary emboli in patients with primary and metastatic brain tumors. Arch Intern Med 1987;147:2177-2179
49. Schiff D, DeAngelis LM. Therapy of venous thromboembolism in patients with brain metastases. Cancer 1994;73:493-498
50. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas: a simple and reproducible method. Cancer 1988; 62:2152-2165
51. Shaw EG, Scheithauer B, O'Fallon J. Astrocytoma. oligoastrocytoma, and oligodendrogliomas: a comparative survival study. [Abstract] Neurology 1992;42(suppl 3):342
52. Leighton C, Fisher B, Bauman G, et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol 1997;15:1294-1301